Humana Inc. (NYSE:HUM) Shares Purchased by State of Tennessee Department of Treasury

State of Tennessee Department of Treasury lifted its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 32.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 44,789 shares of the insurance provider's stock after buying an additional 10,919 shares during the quarter. State of Tennessee Department of Treasury's holdings in Humana were worth $11,363,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Pinnacle Wealth Management Advisory Group LLC lifted its stake in Humana by 3.6% during the fourth quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider's stock worth $272,000 after purchasing an additional 37 shares during the last quarter. Atlas Brown Inc. lifted its holdings in Humana by 0.6% in the fourth quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider's stock worth $1,611,000 after buying an additional 38 shares during the period. Mather Group LLC. grew its stake in Humana by 21.0% in the fourth quarter. Mather Group LLC. now owns 236 shares of the insurance provider's stock worth $60,000 after purchasing an additional 41 shares during the period. Capital Advisors Ltd. LLC increased its stake in shares of Humana by 26.1% in the 4th quarter. Capital Advisors Ltd. LLC now owns 208 shares of the insurance provider's stock worth $53,000 after acquiring an additional 43 shares in the last quarter. Finally, Retirement Planning Co of New England Inc. lifted its holdings in shares of Humana by 4.7% during the fourth quarter. Retirement Planning Co of New England Inc. now owns 966 shares of the insurance provider's stock valued at $245,000 after purchasing an additional 43 shares during the last quarter. 92.38% of the stock is owned by institutional investors.

Humana Stock Performance

Shares of NYSE:HUM traded down $3.91 during trading on Friday, reaching $263.92. The company had a trading volume of 1,097,942 shares, compared to its average volume of 1,747,221. The firm has a market capitalization of $31.85 billion, a price-to-earnings ratio of 26.52, a price-to-earnings-growth ratio of 2.05 and a beta of 0.62. The stock's fifty day moving average price is $266.35 and its 200 day moving average price is $270.67. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46.

Humana (NYSE:HUM - Get Free Report) last issued its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, equities research analysts predict that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be issued a $0.885 dividend. The ex-dividend date is Friday, June 27th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.34%. Humana's dividend payout ratio (DPR) is presently 35.58%.

Analyst Upgrades and Downgrades

Several brokerages have commented on HUM. Robert W. Baird increased their target price on Humana from $270.00 to $300.00 and gave the company a "neutral" rating in a research note on Tuesday, April 15th. Barclays lifted their price target on shares of Humana from $270.00 to $322.00 and gave the stock an "equal weight" rating in a research note on Friday, April 11th. JPMorgan Chase & Co. reduced their target price on shares of Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a report on Tuesday, February 18th. Cantor Fitzgerald restated a "neutral" rating and issued a $290.00 price objective on shares of Humana in a research report on Wednesday, February 12th. Finally, StockNews.com raised shares of Humana from a "hold" rating to a "buy" rating in a research note on Monday, April 7th. Seventeen research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $284.90.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.